Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has been used in the treatment of diabetes for decades. Devices have evolved with technological advancements; some insulin pumps now feature Bluetooth connectivity and complementary smartphone applications while the use of AI technology is slowly being integrated. Modern insulin pumps are both more patient and physician-friendly as they allow for precise insulin control in diabetic patients. As a result, the number of pump users has increased manifold now totaling an estimated 350,000 patients within the United States.
July 18, 2019